Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1997-08

AUTHORS

Mark Roman, Elena Martin-Orozco, Justin S. Goodman, Minh-Duc Nguyen, Yukio Sato, Arash Ronaghy, Richard S. Kornbluth, Douglas D. Richman, Dennis A. Carson, Eyal Raz

ABSTRACT

An adjuvant role for certain short bacterial immunostimulatory DNA sequences (ISSs) has recently been proposed on the basis of their ability to stimulate T helper-1 (Thl) responses in gene-vaccinated animals. We report here that noncoding, ISS-enriched plasmid DMAs or ISS oligonucleotides (ISS-ODNs) potently stimulate immune responses to coadministered antigens. The ISS-DNAs suppress IgE synthesis, but promote IgC and interferon-γ (IFN-γ) production. They furthermore initiate the production of IFN-γ, IFN-α, IFN-β, and interleukins 12 and 18, all of which foster Thl responses and enhance cell-mediated immunity. Consideration should be given to adding noncoding DNA adjuvants to inactivated or subunit viral vaccines that, by themselves, provide only partial protection from infection. More... »

PAGES

849-854

Journal

TITLE

Nature Medicine

ISSUE

8

VOLUME

3

Related Patents

  • Method For Enhancing An Immune Response
  • Immunostimulatory Nucleic Acid Molecules
  • Method Of Treating Inflammatory Arthropathies With Suppressors Of Cpg Oligonucleotides
  • Use Of Cpg Oligonucleotides In The Treatment Of Hepatitis C Virus Infection
  • Immunomodulatory Compositions, Formulations, And Methods For Use Thereof
  • Which Contains A Cytosine, Guanine Dinucleotide Sequence And Stimulates (For Example, Has A Mitogenic Effect) Vertebrate Immune Cells
  • Methods And Compositions For Eliciting An Immune Response Against Hepatitis B Virus
  • Ige Ch3 Peptide Vaccine
  • For Extending Clinical Utility Of Ifn-Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Invention Provides Methods Which Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Administering Nucleic Acid To Activate Surface Antigen; Anticancer Agents
  • Biodrug Delivery A Guanosine-Rich Dna Oligonucleotide Or Polynucleotides; Acute Respiratory Distress Syndrome, Pneumonia, Respiratory System Disorders; Reducing The Production Of Cytokine Or Chemokine
  • Oligonucleotides Having A '5tcg Motif Without Any Additional Unmethylated Cpg Motifs Have Strong Immunostimulatory Capability
  • Method Of Reducing Inflammatory Infiltration In Subjects With Inflammatory Lung Disease
  • Methods Of Using Immunostimulatory Nucleic Acid Molecules To Treat Allergic Conditions
  • Lipid Nanoparticle Vaccine Adjuvants And Antigen Delivery Systems
  • Method Of Treating Inflammatory Arthropathies With Suppressors Of Cpg Oligonucleotides
  • Processes For Packaging Oligonucleotides Into Virus-Like Particles Of Rna Bacteriophages
  • Oligodeoxynucleotide And Its Use To Induce An Immune Response
  • Enhancement Of Bactericidal Activity Of Neisseria Antigens With Oligonucleotides Containing Cg Motifs
  • For Treatment Of Atopic Conditions (Dermatitis, Allergies) And Influenza Virus; Point Mutations
  • Nanocarrier Compositions With Uncoupled Adjuvant
  • Targeted Synthetic Nanocarriers With Ph Sensitive Release Of Immunomodulatory Agents
  • Plasmids With Immunological Action
  • Method Of Epitope Discovery
  • Sequences With Unmethylated Cpg (Cytosine-Guanine) Dinucleotides That Modulate An Immune Response Including Stimulating A Th1 Pattern Of Immune Activation, Cytokine Production, Nk Lytic Activity, And B Cell Proliferation, Also
  • Enhancement Of Immune Response To Vaccine By Interferon Alpha
  • Multivalent Synthetic Nanocarrier Vaccines
  • Packaging Of Immunostimulatory Substances Into Virus-Like Particles: Method Of Preparation And Use
  • Immunogenic Complexes And Methods Relating Thereto
  • Immunostimulatory Sequence Oligonucleotides And Methods Of Using The Same
  • Nanoparticle-Based Compositions
  • Immunostimulatory Nucleic Acid Molecules
  • Immunostimulatory Nucleic Acid Molecules
  • Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens
  • Rotavirus Antigens
  • Combination Of A Pd-1 Antagonist And Cpg-C Type Oligonucleotide For Treating Cancer
  • Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens
  • Synthetic Nanocarriers That Generate Humoral And Cytotoxic T Lymphocyte (Ctl) Immune Responses
  • Methods And Compositions For Inhibition Of Immune Responses And Autoimmunity
  • Method Of Treating Inflammatory Arthropathies With Supressors Of Cpg Oligonucleotides
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same
  • Nonmalignant B Lymphocyte Cell Comprising A Plasmid Vector; Dna Vaccination
  • Long Term Disease Modification Using Immunostimulatory Oligonucleotides
  • Method Of Treating Inflammatory Lung Disease With Suppressors Of Cpg Oligonucleotides
  • Contacting Dendritic Cell With An Isolated Nucleic Acid Containing At Least One Unmethylated Cpg Dinucleotide Wherein The Nucleic Acid Is From 8-80 Bases In Length In An Amount Effective To Activate Dendritic Cell
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same-Iv
  • Pcsk9 Peptide Vaccine Conjugated To A Qbeta Carrier And Methods Of Using The Same
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same—Iii
  • Immunomodulatory Polynucleotides In Treatment Of An Infection By An Intracellular Pathogen
  • Methods Of Treatment Using Tlr7 And/Or Tlr9 Inhibitors
  • Immunomodulatory Formulations And Methods For Use Thereof
  • Methods And Compositions For Inhibition Of Immune Responses And Autoimmunity
  • Immunostimulatory Nucleic Acid Molecules
  • Composition Comprising Whole-Killed Hiv Virus Devoid Of Outer Envelope Protein Gp 120, Isolated Nucleic Acid Molecule Containing Immunostimulatory Sequence, And Adjuvant; Synergistically Enhances Beta-Chemokine Levels In Mammals
  • Enhancing The Immunogenicity Of A Vaccine Against Bacillus Anthracis By Administering An Oligodeoxynucleotide With A Vaccine Against Bacillus Anthracis; Anthrax Vaccine Adsorbed (Ava) Vaccine
  • Long Term Disease Modification Using Immunostimulatory Oligonucleotides
  • Plasmid With Immunological Action
  • Dose Selection Of Adjuvanted Synthetic Nanocarriers
  • Immunonanotherapeutics Providing A Th1-Biased Response
  • Immunostimulatory Oligonucleotide Compositions. These Oligonucleotides Comprise An Immunostimulatory Octanucleotide Sequence. These Oligonucleotides Can Be Administered In Conjunction With An Immunostimulatory Peptide Or Antigen.
  • Administering Immunopotentiating Cytokine Selected From Group Consisting Of Gm-Csf, Il-2, Il-4 And Ifn-.Gamma., And Immunostimulatory Cpg Oligonucleotide For Inducing Synergistic Antigen Specific Immune Response
  • Mycobacterial Disease, Malaria, Leishmaniasis, Toxoplasmosis, Schistosomiasis And Clonorchiasis; Antiallergens; Asthma
  • Methods Of Ameliorating Symptoms Of Herpes Infection Using Immunomodulatory Polynucleotide Sequences
  • For Extending Clinical Utility Of Interferon (Ifn) Alpha In Treatment Of A Variety Of Viral And Proliferative Disorders; Increase Efficacy Of Ifn- Alpha And Reduce Ifn- Alpha Treatment-Related Side Effects
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same—Iv
  • Methods And Compositions For Eliciting An Immune Response Against Hepatitis B Virus
  • Porcine Reproductive And Respiratory Syndrome Virus Compositions And Uses Thereof
  • Composition Comprising Pcsk9 Peptide Conjugated To A Qbeta Carrier And Methods Of Using The Same
  • Immunomodulatory Compositions, Methods Of Making, And Methods Of Use Thereof
  • Immunostimulatory Nucleic Acid Packaged Particles For The Treatment Of Hypersensitivity
  • An Immunogen And A Cationic Liposome Containing A Nonexpression Nucleic Acid Molecule Or Vector To Elicit A Systemic, Non-Antigen-Specific Immune Response Or A Protective Immune Response Against Allergic Inflammation; Antineopleastic Agents
  • Ige Ch3 Peptide Vaccine
  • Use Of Cpg Oligodeoxynucleotides To Induce Epithelial Cell Growth
  • Olioodeoxynucleotide And Its Use To Induce An Immune Response
  • Combination Motif Immune Stimulatory Oligonucleotides With Improved Activity
  • Methods Of Suppressing Hepatitis Virus Infection Using Immunomodulatory Polynucleotide Sequences
  • Enhancement Of Immune Response To Vaccine By Interferon Alpha
  • Administering To A Subject Suffering From Gastrointestinal Inflammation A Formulation Comprising An Immunomodulatory Nucleic Acid To The Subject, The Immunomodulatory Nucleic Acid Comprising The Sequence 5'-Cpg-3'
  • Methods And Compositions For Eliciting An Immune Response Against Hepatitis B Virus
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Method Of Treating Cancer Using Immunostimulatory Oligonucleotides
  • Nanoparticle-Based Compositions
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same-Ii
  • Oligodeoxynucleotide And Its Use To Induce An Immune Response
  • Ige Ch3 Peptide Vaccine
  • Modified Nicotinic Compounds And Related Methods
  • Methods For Administering Synthetic Nanocarriers That Generate Humoral And Cytotoxic T Lymphocyte Responses
  • Immunomodulatory Formulations And Methods For Use Thereof
  • Use Of Sterically Stabilized Cationic Liposomes To Efficiently Deliver Cpg Oligonucleotides In Vivo
  • Method Of Preventing Infections From Bioterrorism Agents With Immunostimulatory Cpg Oligonucleotides
  • Toll-Like Receptor Modulators And Treatment Of Diseases
  • Immunostimulatory Nucleic Acid Molecules
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Induces Production Of A Cytokine Or Activates Dendritic Cells, Natural Killer Cells And Monocytes; Autoimmune Disorders; Vaccine
  • Expression Vectors Encoding Epitopes Of Target-Associated Antigens And Methods For Their Design
  • Administering To A Lymphoid Tissue In Vivo A Plasmid Vector Containing A Nucleic Acid Molecule Comprising A B Cell Specific Expression Element Operationally Linked To A Nucleic Acid Sequence Encoding One Or More Heterologous Epitopes
  • Use Of Nucleic Acids Containing Unmethylated Cpc Dinucleotide In The Treatment Of Lps-Associated Disorders
  • Immunomodulatory Formulations And Methods For Use Thereof
  • Multiple Cpg Oligodeoxynucleotide And Their Use To Induce An Immune Response
  • Mixture Of Oligonucleotides With Various Nucleotide Sequences
  • Expression Vectors Encoding Epitopes Of Target-Associated Antigens And Methods For Their Design
  • Process For Production Of Helicobacter Pylori Bacterioferritin
  • Ameliorating An Immune System Deficiency In A Subject, Comprising The Steps Of Contacting Lymphocytes Obtained From The Subject With An Antigen And An Immunostimulatory Nucleic Acid
  • Suppressing An Immune Response In Rheumatoid Arthritis By Administering A Pure Or Isolated Oligodeoxynucleotide Of Up To 100 Nucleotides In Length Along With An Additional Antiinflammatory Agent, Immunosuppressive Agent Or Antiarthritis Agent
  • Methods And Products Related To Treatment And Prevention Of Hepatitis C Virus Infection
  • Immune Stimulation By Phosphorothioate Oligonucleotide Analogs
  • Treating Asthma, Immunostimulatory Polynucleotide Comprising An Immunostimulatory Sequence (Iss), Wherein The Iss Comprises The Sequence 5'-Cytosine-Guanine-3'
  • Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens
  • Biodegradable Immunomodulatory Formulations And Methods For Use Thereof
  • Amphiphilic Polyamide Compounds
  • Asthma; Ellergy Vaccine; Antisense Therapy; Used To Treat, Prevent, Or Ameliorate The Symptoms Resulting From Exposure To A Bio-Warfare Agent
  • Compositions That Induce T Cell Help
  • Hiv-1 Tat, Or Derivatives Thereof For Prophylactic And Therapeutic Vaccination
  • Porcine Reproductive And Respiratory Syndrome Virus Compositions And Uses Thereof
  • Packaging Of Immunostimulatory Substances Into Virus-Like Particles: Method Of Preparation And Use
  • Immunostimulatory Nucleic Acid Molecules
  • Use Of Nucleic Acids Containing Unmethylated Cpg Dinucleotide As An Adjuvant
  • Method For Inducing Mucosal Immunity
  • Toll-Like Receptor Modulators And Treatment Of Diseases
  • Immunomodulatory Formulations And Methods For Use Thereof
  • Compositions For Stimulation Of Mammalian Innate Immune Resistance To Pathogens
  • Therapeutic Vaccine Anti-Hiv, Anti-Aids And Against Tumors And Syndromes Associated With Hiv Infection
  • Methods And Compositions For Inhibition Of Innate Immune Responses And Autoimmunity
  • Modified Polynucleotides Have At Least One Phosphorothioate Linkage; Animal Growth Regulators; Immunomodulation, Immunotherapy; Nontoxic
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Comprising A Negatively Charged Organic Carrier And A Positively Charged Antigen; For Facilitating The Induction Of A Cytotoxic T-Lymphocyte Response To An Antigen
  • Nanocarriers Possessing Components With Different Rates Of Release
  • Dose Selection Of Adjuvanted Synthetic Nanocarriers
  • Methods Of Modulating An Immune Response Using Immunostimulatory Sequences And Compositions For Use Therein
  • Immunostimulatory Sequence Oligonucleotides And Methods Of Using The Same
  • Immunostimulatory Sequence Oligonucleotides And Methods Of Using The Same
  • Processes For Packaging Aggregated Oligonucleotides Into Virus-Like Particles Of Rna Bacteriophages
  • Nucleic Acid Compositions For Stimulating Immune Responses
  • Methods And Compositions For Treatment With Synthetic Nanocarriers And Immune Checkpoint Inhibitors
  • Ige Ch3 Peptide Vaccine
  • Nucleotide Vector Vaccine For Immunization Against Hepatitis
  • Incubating Monocytes In Nutrient Broth Comprising Interleukins, Cytokine And Modified Nucleotide Sequences; Propagate Cells; Recover Antigen-Presenting Dendritic Cell, Contact With T-Lymphocyte
  • Compositions And Methods For Treating Viral Infections Through Stimulated Innate Immunity In Combination With Antiviral Compounds
  • Long Term Disease Modification Using Immunostimulatory Oligonucleotides
  • Methods Of Preventing And Treating Respiratory Viral Infection Using Immunomodulatory Polynucleotide Sequences
  • Methods And Products For Inducing Mucosal Immunity
  • Chimeric Immunomodulatory Compounds And Methods Of Using The Same-Iv
  • Immunostimulatory Sequence Oligonucleotides And Methods Of Using The Same
  • Administering Nucleic Acid As Antiinflammatory Agent
  • Use Of Cpg Oligodeoxynucleotides To Induce Angiogenesis
  • Methods Of Treatment Using Tlr7 And/Or Tlr9 Inhibitors
  • Modulate Immunology Response; Asthma Therapy; Autoimmune Disease
  • Lipid Nanoparticle Vaccine Adjuvants And Antigen Delivery Systems
  • Nucleic Acids Containing Unmethylated Cytosine-Guanine Dinucleotides Activate Lymphocytes And Redirect An Immune Response From Th2 To Th1
  • Immunostimulatory Sequence Oligonucleotides And Methods Of Using The Same
  • Modulating Cell Death In A Eukaryotic Cell By Contacting The Cell With An Agent That Modulates A Biological Activity Of Dna-Dependent Protein Kinase
  • Immunizing Compositions Comprising Hiv-1 Proviral Constructs With An Inactive P6 Gag Tsg101 Uev Binding Domain Capable Of Producing Budding-Defective Viral Particles That Remain Tethered To The Cell Surface
  • Ige Ch3 Peptide Vaccine
  • Immunostimulatory Polynucleotide/Immunomodulatory Molecule Conjugates
  • Vectors And Methods For Immunization Or Therapeutic Protocols
  • Immunomodulatory Formulations And Methods For Use Thereof
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nm0897-849

    DOI

    http://dx.doi.org/10.1038/nm0897-849

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1029267096

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9256274


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adjuvants, Immunologic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibody Formation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin E", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin G", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interleukins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphocyte Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Macrophage Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Th1 Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "beta-Galactosidase", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Roman", 
            "givenName": "Mark", 
            "id": "sg:person.01256471704.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256471704.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Martin-Orozco", 
            "givenName": "Elena", 
            "id": "sg:person.01161604627.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161604627.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Goodman", 
            "givenName": "Justin S.", 
            "id": "sg:person.01227720027.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227720027.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nguyen", 
            "givenName": "Minh-Duc", 
            "id": "sg:person.01344546713.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344546713.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine II, Fukushima Medical College, 960-12, Fukushima, Japan", 
              "id": "http://www.grid.ac/institutes/grid.411582.b", 
              "name": [
                "Department of Internal Medicine II, Fukushima Medical College, 960-12, Fukushima, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sato", 
            "givenName": "Yukio", 
            "id": "sg:person.01253172765.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253172765.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ronaghy", 
            "givenName": "Arash", 
            "id": "sg:person.01026310573.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026310573.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "Department of Medicine, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kornbluth", 
            "givenName": "Richard S.", 
            "id": "sg:person.01113275463.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113275463.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "San Diego Veterans Affairs Medical Center and Departments of Medicine and Pathology, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California", 
              "id": "http://www.grid.ac/institutes/grid.266100.3", 
              "name": [
                "San Diego Veterans Affairs Medical Center and Departments of Medicine and Pathology, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Richman", 
            "givenName": "Douglas D.", 
            "id": "sg:person.0772641340.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772641340.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Carson", 
            "givenName": "Dennis A.", 
            "id": "sg:person.010273067252.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010273067252.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Raz", 
            "givenName": "Eyal", 
            "id": "sg:person.01210450171.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210450171.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nm1096-1122", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052270183", 
              "https://doi.org/10.1038/nm1096-1122"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/374546a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034049921", 
              "https://doi.org/10.1038/374546a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/378088a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021750623", 
              "https://doi.org/10.1038/378088a0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1997-08", 
        "datePublishedReg": "1997-08-01", 
        "description": "An adjuvant role for certain short bacterial immunostimulatory DNA sequences (ISSs) has recently been proposed on the basis of their ability to stimulate T helper-1 (Thl) responses in gene-vaccinated animals. We report here that noncoding, ISS-enriched plasmid DMAs or ISS oligonucleotides (ISS-ODNs) potently stimulate immune responses to coadministered antigens. The ISS-DNAs suppress IgE synthesis, but promote IgC and interferon-\u03b3 (IFN-\u03b3) production. They furthermore initiate the production of IFN-\u03b3, IFN-\u03b1, IFN-\u03b2, and interleukins 12 and 18, all of which foster Thl responses and enhance cell-mediated immunity. Consideration should be given to adding noncoding DNA adjuvants to inactivated or subunit viral vaccines that, by themselves, provide only partial protection from infection.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nm0897-849", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2590104", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2453185", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2435302", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1113716", 
            "issn": [
              "1078-8956", 
              "1546-170X"
            ], 
            "name": "Nature Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "8", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "3"
          }
        ], 
        "keywords": [
          "immunostimulatory DNA sequences", 
          "T helper", 
          "cell-mediated immunity", 
          "production of IFN", 
          "Thl response", 
          "adjuvant role", 
          "DNA adjuvants", 
          "interleukin-12", 
          "IgE synthesis", 
          "immune response", 
          "viral vaccines", 
          "partial protection", 
          "IFN", 
          "adjuvant", 
          "helper", 
          "response", 
          "vaccine", 
          "infection", 
          "antigen", 
          "immunity", 
          "animals", 
          "role", 
          "protection", 
          "function", 
          "ability", 
          "noncoding", 
          "production", 
          "consideration", 
          "basis", 
          "DNA sequences", 
          "sequence functions", 
          "synthesis", 
          "DMAS", 
          "IGC", 
          "sequence"
        ], 
        "name": "Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants", 
        "pagination": "849-854", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1029267096"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nm0897-849"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9256274"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nm0897-849", 
          "https://app.dimensions.ai/details/publication/pub.1029267096"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_290.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nm0897-849"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nm0897-849'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nm0897-849'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nm0897-849'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nm0897-849'


     

    This table displays all metadata directly associated to this object as RDF triples.

    245 TRIPLES      21 PREDICATES      79 URIs      68 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nm0897-849 schema:about N00433a87889148aaa247a870fdafb3d8
    2 N0a175d74fb0a493d8fe96a9d34cf988c
    3 N315d44d5d2c14e35859ff30380443413
    4 N49f87af98ce04f0f816952819b902679
    5 N57578bf808d040a39e7ab6c50be75235
    6 N66b9daaf0aa54f28bcae622dbdbe764c
    7 N6972c1ec99284023bf982ca4dd356466
    8 N81bf509015ec4a27b6a7dd13a6b50119
    9 Nccde379a32794854983f291871413bd2
    10 Nce126668ad9c4deabe88ca047fefe3ee
    11 Nd29bd4ea7623489788d9d38c6c31d3c2
    12 Nd634e5ed6cdc420aa7a126ea4f15a902
    13 Nef9130409b9347e88b4171aa7b79bded
    14 Nf4f25801dde549edb81cb4e85400cb74
    15 Nf98a1d6db75a48f7a8f1e88a07c048cf
    16 anzsrc-for:11
    17 anzsrc-for:1107
    18 schema:author N1f28033c2c994e2995f0db5f4138f1ae
    19 schema:citation sg:pub.10.1038/374546a0
    20 sg:pub.10.1038/378088a0
    21 sg:pub.10.1038/nm1096-1122
    22 schema:datePublished 1997-08
    23 schema:datePublishedReg 1997-08-01
    24 schema:description An adjuvant role for certain short bacterial immunostimulatory DNA sequences (ISSs) has recently been proposed on the basis of their ability to stimulate T helper-1 (Thl) responses in gene-vaccinated animals. We report here that noncoding, ISS-enriched plasmid DMAs or ISS oligonucleotides (ISS-ODNs) potently stimulate immune responses to coadministered antigens. The ISS-DNAs suppress IgE synthesis, but promote IgC and interferon-γ (IFN-γ) production. They furthermore initiate the production of IFN-γ, IFN-α, IFN-β, and interleukins 12 and 18, all of which foster Thl responses and enhance cell-mediated immunity. Consideration should be given to adding noncoding DNA adjuvants to inactivated or subunit viral vaccines that, by themselves, provide only partial protection from infection.
    25 schema:genre article
    26 schema:isAccessibleForFree true
    27 schema:isPartOf N0e15e6e93c5640fca44358a058192bc2
    28 N326f8b2666a04ea58f7587eeb37821c9
    29 sg:journal.1113716
    30 schema:keywords DMAS
    31 DNA adjuvants
    32 DNA sequences
    33 IFN
    34 IGC
    35 IgE synthesis
    36 T helper
    37 Thl response
    38 ability
    39 adjuvant
    40 adjuvant role
    41 animals
    42 antigen
    43 basis
    44 cell-mediated immunity
    45 consideration
    46 function
    47 helper
    48 immune response
    49 immunity
    50 immunostimulatory DNA sequences
    51 infection
    52 interleukin-12
    53 noncoding
    54 partial protection
    55 production
    56 production of IFN
    57 protection
    58 response
    59 role
    60 sequence
    61 sequence functions
    62 synthesis
    63 vaccine
    64 viral vaccines
    65 schema:name Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
    66 schema:pagination 849-854
    67 schema:productId N2cd27f51b332419fbc8aa5a3e4fd1860
    68 N5752296742384f4395270d8c3005d35d
    69 N732eec70911c4affb6b136b95bedb20b
    70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029267096
    71 https://doi.org/10.1038/nm0897-849
    72 schema:sdDatePublished 2022-11-24T20:48
    73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    74 schema:sdPublisher N48e8f4cf37144a10be6d9834e4c546fa
    75 schema:url https://doi.org/10.1038/nm0897-849
    76 sgo:license sg:explorer/license/
    77 sgo:sdDataset articles
    78 rdf:type schema:ScholarlyArticle
    79 N00433a87889148aaa247a870fdafb3d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    80 schema:name Macrophage Activation
    81 rdf:type schema:DefinedTerm
    82 N0a175d74fb0a493d8fe96a9d34cf988c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Immunoglobulin E
    84 rdf:type schema:DefinedTerm
    85 N0e15e6e93c5640fca44358a058192bc2 schema:issueNumber 8
    86 rdf:type schema:PublicationIssue
    87 N1f28033c2c994e2995f0db5f4138f1ae rdf:first sg:person.01256471704.50
    88 rdf:rest N22f64da628894414ab0a78adb4e758b4
    89 N206e9190b1fe49feb9777d49bb94541d rdf:first sg:person.01210450171.38
    90 rdf:rest rdf:nil
    91 N22f64da628894414ab0a78adb4e758b4 rdf:first sg:person.01161604627.19
    92 rdf:rest N2f2eef3fd86849cb9ec74af15b9df178
    93 N2cd27f51b332419fbc8aa5a3e4fd1860 schema:name dimensions_id
    94 schema:value pub.1029267096
    95 rdf:type schema:PropertyValue
    96 N2f2eef3fd86849cb9ec74af15b9df178 rdf:first sg:person.01227720027.63
    97 rdf:rest N912be0e0143047079bb35a7a0a5c35bf
    98 N315d44d5d2c14e35859ff30380443413 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Adjuvants, Immunologic
    100 rdf:type schema:DefinedTerm
    101 N326f8b2666a04ea58f7587eeb37821c9 schema:volumeNumber 3
    102 rdf:type schema:PublicationVolume
    103 N48e8f4cf37144a10be6d9834e4c546fa schema:name Springer Nature - SN SciGraph project
    104 rdf:type schema:Organization
    105 N49f87af98ce04f0f816952819b902679 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    106 schema:name Lymphocyte Activation
    107 rdf:type schema:DefinedTerm
    108 N5752296742384f4395270d8c3005d35d schema:name pubmed_id
    109 schema:value 9256274
    110 rdf:type schema:PropertyValue
    111 N57578bf808d040a39e7ab6c50be75235 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Female
    113 rdf:type schema:DefinedTerm
    114 N66b9daaf0aa54f28bcae622dbdbe764c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Interferons
    116 rdf:type schema:DefinedTerm
    117 N6972c1ec99284023bf982ca4dd356466 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name DNA
    119 rdf:type schema:DefinedTerm
    120 N732eec70911c4affb6b136b95bedb20b schema:name doi
    121 schema:value 10.1038/nm0897-849
    122 rdf:type schema:PropertyValue
    123 N75cbbc175264450d926574bb460c3406 rdf:first sg:person.01253172765.68
    124 rdf:rest N940c98cd65864ae6802033e26dc2dace
    125 N81bf509015ec4a27b6a7dd13a6b50119 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Immunoglobulin G
    127 rdf:type schema:DefinedTerm
    128 N912be0e0143047079bb35a7a0a5c35bf rdf:first sg:person.01344546713.86
    129 rdf:rest N75cbbc175264450d926574bb460c3406
    130 N930b613d277d4a2bb526985f47b64cd6 rdf:first sg:person.010273067252.22
    131 rdf:rest N206e9190b1fe49feb9777d49bb94541d
    132 N940c98cd65864ae6802033e26dc2dace rdf:first sg:person.01026310573.19
    133 rdf:rest Neaec15f9ffd94e91b9e234dc772cd567
    134 Nccde379a32794854983f291871413bd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Antibody Formation
    136 rdf:type schema:DefinedTerm
    137 Nce126668ad9c4deabe88ca047fefe3ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Mice, Inbred BALB C
    139 rdf:type schema:DefinedTerm
    140 Nd29bd4ea7623489788d9d38c6c31d3c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Animals
    142 rdf:type schema:DefinedTerm
    143 Nd634e5ed6cdc420aa7a126ea4f15a902 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Mice
    145 rdf:type schema:DefinedTerm
    146 Neaec15f9ffd94e91b9e234dc772cd567 rdf:first sg:person.01113275463.01
    147 rdf:rest Nf06115f28cfb4a37a9aaa1fb724cc726
    148 Nef9130409b9347e88b4171aa7b79bded schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Th1 Cells
    150 rdf:type schema:DefinedTerm
    151 Nf06115f28cfb4a37a9aaa1fb724cc726 rdf:first sg:person.0772641340.05
    152 rdf:rest N930b613d277d4a2bb526985f47b64cd6
    153 Nf4f25801dde549edb81cb4e85400cb74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name beta-Galactosidase
    155 rdf:type schema:DefinedTerm
    156 Nf98a1d6db75a48f7a8f1e88a07c048cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Interleukins
    158 rdf:type schema:DefinedTerm
    159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    160 schema:name Medical and Health Sciences
    161 rdf:type schema:DefinedTerm
    162 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    163 schema:name Immunology
    164 rdf:type schema:DefinedTerm
    165 sg:grant.2435302 http://pending.schema.org/fundedItem sg:pub.10.1038/nm0897-849
    166 rdf:type schema:MonetaryGrant
    167 sg:grant.2453185 http://pending.schema.org/fundedItem sg:pub.10.1038/nm0897-849
    168 rdf:type schema:MonetaryGrant
    169 sg:grant.2590104 http://pending.schema.org/fundedItem sg:pub.10.1038/nm0897-849
    170 rdf:type schema:MonetaryGrant
    171 sg:journal.1113716 schema:issn 1078-8956
    172 1546-170X
    173 schema:name Nature Medicine
    174 schema:publisher Springer Nature
    175 rdf:type schema:Periodical
    176 sg:person.01026310573.19 schema:affiliation grid-institutes:None
    177 schema:familyName Ronaghy
    178 schema:givenName Arash
    179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026310573.19
    180 rdf:type schema:Person
    181 sg:person.010273067252.22 schema:affiliation grid-institutes:None
    182 schema:familyName Carson
    183 schema:givenName Dennis A.
    184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010273067252.22
    185 rdf:type schema:Person
    186 sg:person.01113275463.01 schema:affiliation grid-institutes:grid.266100.3
    187 schema:familyName Kornbluth
    188 schema:givenName Richard S.
    189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01113275463.01
    190 rdf:type schema:Person
    191 sg:person.01161604627.19 schema:affiliation grid-institutes:None
    192 schema:familyName Martin-Orozco
    193 schema:givenName Elena
    194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161604627.19
    195 rdf:type schema:Person
    196 sg:person.01210450171.38 schema:affiliation grid-institutes:None
    197 schema:familyName Raz
    198 schema:givenName Eyal
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210450171.38
    200 rdf:type schema:Person
    201 sg:person.01227720027.63 schema:affiliation grid-institutes:None
    202 schema:familyName Goodman
    203 schema:givenName Justin S.
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227720027.63
    205 rdf:type schema:Person
    206 sg:person.01253172765.68 schema:affiliation grid-institutes:grid.411582.b
    207 schema:familyName Sato
    208 schema:givenName Yukio
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253172765.68
    210 rdf:type schema:Person
    211 sg:person.01256471704.50 schema:affiliation grid-institutes:None
    212 schema:familyName Roman
    213 schema:givenName Mark
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256471704.50
    215 rdf:type schema:Person
    216 sg:person.01344546713.86 schema:affiliation grid-institutes:None
    217 schema:familyName Nguyen
    218 schema:givenName Minh-Duc
    219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01344546713.86
    220 rdf:type schema:Person
    221 sg:person.0772641340.05 schema:affiliation grid-institutes:grid.266100.3
    222 schema:familyName Richman
    223 schema:givenName Douglas D.
    224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772641340.05
    225 rdf:type schema:Person
    226 sg:pub.10.1038/374546a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034049921
    227 https://doi.org/10.1038/374546a0
    228 rdf:type schema:CreativeWork
    229 sg:pub.10.1038/378088a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021750623
    230 https://doi.org/10.1038/378088a0
    231 rdf:type schema:CreativeWork
    232 sg:pub.10.1038/nm1096-1122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052270183
    233 https://doi.org/10.1038/nm1096-1122
    234 rdf:type schema:CreativeWork
    235 grid-institutes:None schema:alternateName Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California
    236 schema:name Dynavax Technologies Corporation, 3099 Science Park Road, Suite 200, 92121, San Diego, California
    237 rdf:type schema:Organization
    238 grid-institutes:grid.266100.3 schema:alternateName Department of Medicine, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California
    239 San Diego Veterans Affairs Medical Center and Departments of Medicine and Pathology, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California
    240 schema:name Department of Medicine, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California
    241 San Diego Veterans Affairs Medical Center and Departments of Medicine and Pathology, University of California San Diego, 9500 Oilman Drive, 92093-0679, La Jolla, California
    242 rdf:type schema:Organization
    243 grid-institutes:grid.411582.b schema:alternateName Department of Internal Medicine II, Fukushima Medical College, 960-12, Fukushima, Japan
    244 schema:name Department of Internal Medicine II, Fukushima Medical College, 960-12, Fukushima, Japan
    245 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...